ShareValue scores for 300642.SHE: Valuation 54, Quality 53, Growth 38, Health 43.
300642.SHESZSE
Tellgen Corp
CN¥12.88
(+0.70%)
300642.SHESZSE
Tellgen Corp
CN¥12.88(+0.70%)
Loading chart...
Sentiment
Verdicts
Value:Fair Value
Quality:Moderate
Growth:Weak
Health:Moderate
Verdicts
Fundamental Rating
Value Trap Risk
Expected Return
6% to 16%
Rating
Trap Risk
Return
6% to 16%
Valuation
54
Fair Value
Price vs Value
Quality
53
Moderate
Business Strength
Growth
38
Weak
Revenue & Earnings
Health
43
Moderate
Financial Stability
Momentum
25
Bearish
Price Trend
Company Details
About
Tellgen Corporation researches and develops, manufactures, and distributes IVDs in China and internationally. The company offers tumor markers; cervical cancer and HPV testing kits; Y chromosome microdeletions test kits; autoimmune; tumor methylation; cardiovascular, eugenics, and inflammation. It also provides diagnostic reagents/testing instruments and assembly lines. The company was founded in 2003 and is based in Shanghai, China.
Market Cap$2.09B
P/E RatioN/A
Dividend Yield0.85%
Sector Rank#2045
Score Analysis
AI Investment Thesis
Data as of:Aug 6, 2026
|Last calculated:Aug 6, 2026